Filtered By:
Drug: Hydroxychloroquine

This page shows you your search results in order of date. This is page number 2.

Order by Relevance | Date

Total 18 results found since Jan 2013.

Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients Preventive Cardiology
Conclusion In this hypothesis-generating study, hydroxychloroquine use was associated with a 72% decrease in the risk of incident CVD in RA patients. If these preliminary results are confirmed in larger studies, our findings may be used as a rationale for a randomized study of hydroxychloroquine use for primary prevention of CVD in RA or nonrheumatic high-risk patients.
Source: JAHA:Journal of the American Heart Association - January 4, 2016 Category: Cardiology Authors: Sharma, T. S., Wasko, M. C. M., Tang, X., Vedamurthy, D., Yan, X., Cote, J., Bili, A. Tags: Cardiovascular Disease, Primary Prevention Preventive Cardiology Source Type: research

Childhood-onset systemic polyarteritis nodosa and systemic lupus erythematosus: an overlap syndrome?
In conclusion, we described herein a possible overlap syndrome of two autoimmune diseases, where childhood-onset systemic polyarteritis nodosa occurred five years before the childhood-onset systemic lupus erythematosus diagnosis.
Source: Revista Brasileira de Reumatologia - July 13, 2015 Category: Rheumatology Source Type: research

Common drug for Sjögren’s does not help symptoms
Hydroxychloroquine didn’t reduce dryness, pain or fatigue more than placebo Related items from OnMedicaNewer RA drugs no better than old in keeping patients at workThyroid patients need better monitoringDrugs regulators “put profits before patients”Lupus anticoagulant greatly raises stroke risk
Source: OnMedica Latest News - July 17, 2014 Category: UK Health Source Type: news